These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28870924)
21. Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas. Kafadar AM; Ergen A; Zeybek U; Agachan B; Kuday C; Isbir T Cell Biochem Funct; 2006; 24(5):455-60. PubMed ID: 16142697 [TBL] [Abstract][Full Text] [Related]
22. Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype. Bujko M; Machnicki MM; Grecka E; Rusetska N; Matyja E; Kober P; Mandat T; Rydzanicz M; Płoski R; Krajewski R; Bonicki W; Stokłosa T; Siedlecki JA World Neurosurg; 2017 Jan; 97():754.e1-754.e6. PubMed ID: 27756662 [TBL] [Abstract][Full Text] [Related]
23. Investigation of Caspase 9 Gene Polymorphism in Patients With Non-small Cell Lung Cancer. Ercan S; Arinc S; Yilmaz SG; Altunok C; Yaman F; Isbir T Anticancer Res; 2019 May; 39(5):2437-2441. PubMed ID: 31092436 [TBL] [Abstract][Full Text] [Related]
24. Constitutional p53 mutations associated with brain tumors in young adults. Chen P; Iavarone A; Fick J; Edwards M; Prados M; Israel MA Cancer Genet Cytogenet; 1995 Jul; 82(2):106-15. PubMed ID: 7664239 [TBL] [Abstract][Full Text] [Related]
25. Common genetic variations of deiodinase genes and prognosis of brain tumor patients. Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060 [TBL] [Abstract][Full Text] [Related]
26. Secretory meningioma with KLF4 K409Q mutation in collision with glioma. Ruiz J; Capilla E; Díaz JF; Ruiz JA; Andrade J; Hernández T; Mollejo M; Meléndez B Clin Neuropathol; 2015; 34(6):322-9. PubMed ID: 26227255 [TBL] [Abstract][Full Text] [Related]
27. Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. De Roos AJ; Rothman N; Brown M; Bell DA; Pittman GS; Shapiro WR; Selker RG; Fine HA; Black PM; Inskip PD Neuro Oncol; 2006 Apr; 8(2):145-55. PubMed ID: 16598069 [TBL] [Abstract][Full Text] [Related]
28. Role of the CASP-9 Ex5+32 G>A polymorphism in susceptibility to cancer: A meta-analysis. Yan S; Li YZ; Zhu XW; Liu CL; Wang P; Liu YL Exp Ther Med; 2013 Jan; 5(1):175-180. PubMed ID: 23251262 [TBL] [Abstract][Full Text] [Related]
29. Association between Caspase-9 promoter region polymorphisms and discogenic low back pain. Guo TM; Liu M; Zhang YG; Guo WT; Wu SX Connect Tissue Res; 2011 Apr; 52(2):133-8. PubMed ID: 21091209 [TBL] [Abstract][Full Text] [Related]
30. Association of strong risk of hTERT gene polymorphic variants to malignant glioma and its prognostic implications with respect to different histological types and survival of glioma cases. Pandith AA; Wani ZA; Qasim I; Afroze D; Manzoor U; Amin I; Baba SM; Koul A; Anwar I; Mohammad F; Bhat AR; Shah P J Gene Med; 2020 Nov; 22(11):e3260. PubMed ID: 32783258 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide association analysis identifies a meningioma risk locus at 11p15.5. Claus EB; Cornish AJ; Broderick P; Schildkraut JM; Dobbins SE; Holroyd A; Calvocoressi L; Lu L; Hansen HM; Smirnov I; Walsh KM; Schramm J; Hoffmann P; Nöthen MM; Jöckel KH; Swerdlow A; Larsen SB; Johansen C; Simon M; Bondy M; Wrensch M; Houlston RS; Wiemels JL Neuro Oncol; 2018 Oct; 20(11):1485-1493. PubMed ID: 29762745 [TBL] [Abstract][Full Text] [Related]
32. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630 [TBL] [Abstract][Full Text] [Related]
33. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer. Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278 [TBL] [Abstract][Full Text] [Related]
34. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of DNA repair gene variants and risk of meningioma. Bethke L; Murray A; Webb E; Schoemaker M; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Kosteljanetz M; Swerdlow A; Houlston R J Natl Cancer Inst; 2008 Feb; 100(4):270-6. PubMed ID: 18270339 [TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of EGF 5'-UTR and NAT2 857G/A associated with glioma in a case control study of Malaysian patients. Muthusamy KA; Lian LH; Vairavan N; Chua KH; Waran V Genet Mol Res; 2012 Aug; 11(3):2939-45. PubMed ID: 22782629 [TBL] [Abstract][Full Text] [Related]
37. Involvement of poly(ADP-ribose) polymerase-1 in Chinese patients with glioma: a potential target for effective patient care. Ren J; Jia P; Feng H; Li X; Zhao J; Sun Y Int J Biol Markers; 2018 Jan; 33(1):68-72. PubMed ID: 28777431 [TBL] [Abstract][Full Text] [Related]
38. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer]. Lou Y; Fang CQ; Li JH Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546 [TBL] [Abstract][Full Text] [Related]
39. Risk of meningioma and common variation in genes related to innate immunity. Rajaraman P; Brenner AV; Neta G; Pfeiffer R; Wang SS; Yeager M; Thomas G; Fine HA; Linet MS; Rothman N; Chanock SJ; Inskip PD Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1356-61. PubMed ID: 20406964 [TBL] [Abstract][Full Text] [Related]
40. Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Xavier-Magalhães A; Oliveira AI; de Castro JV; Pojo M; Gonçalves CS; Lourenço T; Viana-Pereira M; Costa S; Linhares P; Vaz R; Nabiço R; Amorim J; Pinto AA; Reis RM; Costa BM J Neurooncol; 2017 Mar; 132(1):27-34. PubMed ID: 28083786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]